Astellas Pharma Inc.

In News

Q2 2026 Astellas Pharma Inc Earnings Presentation Transcript - GuruFocus

GuruFocus - Apr 01, 2026

Astellas Pharma: Advancing flagship assets and pipeline with global reach, innovation, and accelerated productivity - TradingView

TradingView - Mar 31, 2026

Astellas Pharma (OTCMKTS:ALPMY) Sets New 1-Year High - Time to Buy? - MarketBeat

MarketBeat - Mar 30, 2026

Astellas Pharma Inc.: - marketscreener.com

marketscreener.com - Mar 29, 2026

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year? - finance.yahoo.com

finance.yahoo.com - Mar 25, 2026

Why You Might Be Interested In Astellas Pharma Inc. (TSE:4503) For Its Upcoming Dividend - simplywall.st

simplywall.st - Mar 25, 2026

Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer - PR Newswire

PR Newswire - Feb 23, 2026

India's Lupin settles US patent dispute with Astellas Pharma for $90 million - reuters.com

reuters.com - Feb 10, 2026

Trump’s Drug Cost Push Helps Astellas Win Higher Price in Japan - Bloomberg.com

Bloomberg.com - Mar 10, 2026

Astellas Pharmaceuticals Enters $1.7 Billion Global Collaboration with Vir Biotechnology to advance PSMA-targeting PRO-XTEN - Pharmaceutical Executive

Pharmaceutical Executive - Feb 24, 2026

Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference - PR Newswire

PR Newswire - Jan 06, 2026

Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM - finance.yahoo.com

finance.yahoo.com - Mar 01, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment